Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × NSCLC Harboring NRG1 Fusion × zenocutuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1

Conditions

Lethal Congenital Contracture Syndrome 2 2 Pancreatic Neoplasms 1 NSCLC Harboring NRG1 Fusion 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

zenocutuzumab 1 enzalutamide 1 Afatinib 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05588609 2025-09-18

Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers

Merus B.V.

Phase 2 Terminated

GenitourinaryThoracic

NSCLC Harboring NRG1 Fusion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡